RxDoctor Payments Data

Irene Gottlob, MD

Neuro-ophthalmology · Camden, NJNPI 1831869312

Payments from drug & device makers

$6,092in general payments, 2019–2025

Across 31 payments — averaging $196.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$5K
  • EMD Serono, Inc.$154
  • Biogen$142
  • Johnson & Johnson$140
  • Argenx US, Inc.$110
  • AstraZeneca$104
  • plus $18 from 1 others

What the payments were for

  • Speaking & faculty fees$3,85063%
  • Travel & lodging$5138%
  • Food & beverage$1,72828%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)23$5,423
EMD Serono, Inc.3$154
Biogen1$142
Johnson & Johnson1$140
Argenx US, Inc.1$110
AstraZeneca1$104
AbbVie1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neuro-ophthalmology providers in New Jerseyto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$45,392
Medicare patients
103
Services billed
545

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuro-ophthalmology in Camden

Where these figures come from

Is this you, or does something look wrong? →